MEKAWIRE
United States

Remedy Robotics

San Francisco developer of the N1, an AI-enabled robotic system for on-site, remote and autonomous endovascular procedures (investigational).

Remedy Robotics has raised $62M across 1 disclosed round since Nov 16, 2026; the latest round, Series B, was announced on Nov 16, 2026. Data as of Nov 17, 2026.

Headquartered in San Francisco, United States.

Latest from MEKAWIRE

No rival relationships reviewed yet

Rivals are only shown with a stated reason; nothing here is inferred without evidence.

Related companies